Future Directions Forum: Where Can Automation, Advanced Characterisation & Platforms Actually Add Value to the Future of Gene Therapy Analytics?
- Exploring what “potency assurance” will mean in practice over the next five years, moving from individual assays toward integrated strategies that combine starting material control, process understanding, and functional readouts
- Debating the future role of platform analytics versus product-specific methods
- Exploring where digital workflows, standardised data pipelines, and analytical platforms can realistically reduce turnaround time without overselling AI or full end-to-end automation